Clinical Trial

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated October 10, 2025 (before its estimated June 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-3-600 in patients with advanced cancer
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-07-09; most recent amendment 2025-10-08.
Status change: Recruiting → Active, Not Recruiting 2025-10-08
Status change: Not Yet Recruiting → Recruiting 2023-09-29
Trial Details
NCT Number NCT05948826
Lead Sponsor TORL Biotherapeutics, LLC
Collaborators: Translational Research in Oncology
Conditions Advanced Solid Tumor, Colorectal Cancer
Enrollment 70 participants
Start Date 2023-09-29
Primary Completion 2026-06-25 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2025-10-10